The role of adjuvant chemotherapy for patients with stage II and stage III gastric adenocarcinoma after surgery plus D2 lymph node dissection: a real-world observation.

Chiu, Chang-Fang; Yang, Horng-Ren; Yang, Mei-Due; Jeng, Long-Bin; Sargeant, Aaron M; Yeh, Su-Peng; Bai, Li-Yuan

Chiu, Chang-Fang; Yang, Horng-Ren; Yang, Mei-Due; Jeng, Long-Bin; Sargeant, Aaron M; Yeh, Su-Peng; Bai, Li-Yuan.

Afiliación

Chiu CF; Division of Hematology and Oncology, Department of Internal Medicine, China Medical University Hospital, 2, Yude Road, Taichung, 40402 Taiwan ; Cancer Center, China Medical University Hospital, Taichung, 40402 Taiwan ; College of Medicine, School of Medicine, China Medical University, Taichung, 4040
Yang HR; Department of Surgery, China Medical University Hospital, Taichung, 40402 Taiwan.
Yang MD; Department of Surgery, China Medical University Hospital, Taichung, 40402 Taiwan.
Jeng LB; Department of Surgery, China Medical University Hospital, Taichung, 40402 Taiwan.
Sargeant AM; Charles River Laboratories, Preclinical Services, Spencerville, OH 45887 USA.
Yeh SP; Division of Hematology and Oncology, Department of Internal Medicine, China Medical University Hospital, 2, Yude Road, Taichung, 40402 Taiwan ; College of Medicine, School of Medicine, China Medical University, Taichung, 40402 Taiwan.
Bai LY; Division of Hematology and Oncology, Department of Internal Medicine, China Medical University Hospital, 2, Yude Road, Taichung, 40402 Taiwan ; College of Medicine, School of Medicine, China Medical University, Taichung, 40402 Taiwan.

Springerplus ; 5(1): 728, 2016.

Article en En | MEDLINE | ID: mdl-27375997